Inhibition of GTP cyclohydrolase reduces cancer pain in mice and enhances analgesic effects of morphine
Inhibition of GTP cyclohydrolase reduces cancer pain in mice and enhances analgesic effects of morphine
复制标题
抑制 GTP 环水解酶可减轻小鼠癌症疼痛并增强吗啡的镇痛作用
DOI:
10.1007/s00109-012-0927-7
复制
发表时间:
2012
期刊:
影响因子:
--
通讯作者:
Tegeder I.
中科院分区:
文献类型:
--
作者:
Pickert G;Myrczek T;Rückert S;Weigert A;Häussler A;Ferreirós N;Brüne B;Lötsch J;Tegeder I.
Noncoding polymorphisms of the GTP cyclohydrolase gene (GCH1) reduce the risk for chronic pain in humans suggesting GCH1 inhibitors as analgesics. We assessed the effects of the GCH1 inhibitor diaminohydroxypyrimidine (DAHP) on nociception and inflammation in a mouse melanoma and a sarcoma cancer pain model, and its co-effects with morphine in terms of analgesic efficacy and respiratory depression. GCH1 inhibition did not reduce the tumor-evoked nociceptive hypersensitivity of the tumor-bearing paw. However, DAHP reduced melanoma- and sarcoma-evoked systemic hyperalgesia as determined by analyzing contralateral paws. GCH1 inhibition increased the inflammatory edema and infiltration with polymorphonuclear leukocytes surrounding the tumor but reduced the tumor-evoked microglia activation in the spinal cord suggesting that an increase of the local immune attack against the tumor may avoid general pain hypersensitivity. When used in combination with morphine at high or low doses, GCH1 inhibition increased and prolonged the analgesic effects of the opioid. It did not, however, increase the respiratory depression caused by morphine. Conversely, the GCH1-product, tetrahydrobiopterin, caused hyperalgesia, antagonized antinociceptive effects of morphine, and aggravated morphine-evoked respiratory depression, the latter mimicked by a cGMP analog suggesting that respiratory effects were partly mediated through the BH4–NO–cGMP pathway. The observed effects of GCH1 inhibition in the tumor model and its enhancement of morphine-evoked antinociception without increase of morphine toxicity suggest that GCH1 inhibitors might be useful as co-therapeutics for opioids in cancer patients.
登录
查看更多内容
DOI:
10.1152/japplphysiol.90548.2008
发表时间:
2009
期刊:
Journal of applied physiology (Bethesda, Md. : 1985)
影响因子:
--
作者:
Krause,KL;Neumueller,SE;Marshall,BD;Kiner,T;Bonis,JM;Pan,LG;Qian,B;Forster,HV
通讯作者:
Forster,HV
影响因子:
2.9
作者:
Doehring, Alexandra;Freynhagen, Rainer;Loetsch, Joern
通讯作者:
Loetsch, Joern
影响因子:
9.7
作者:
K. Schroecksnadel;B. Frick;C. Winkler;L. Fuith;D. Fuchs
通讯作者:
D. Fuchs
DOI:
10.1073/pnas.1002404107
发表时间:
2010-08-03
影响因子:
11.1
作者:
Watschinger, Katrin;Keller, Markus A.;Werner, Ernst R.
通讯作者:
Werner, Ernst R.
影响因子:
5.3
作者:
Sunghee Cho;B. Volpe;Y. Bae;O. Hwang;H. Choi;J. Gal;L. Park;C. K. Chu;Jinfa Du;T. Joh
通讯作者:
T. Joh